A Descriptive Analysis from VigiAccess on Drug-related ProblemsAssociated with the Glucagon-like Peptide-1 Receptor Agonists

Qualified healthcare practitioners must educate the patients administering the GLP- 1 RAs to minimize preventable DRPs. Also, careful and frequent monitoring of GLP-1 RAs improves therapeutic outcomes by ruling out DRPs. Healthcare practitioners should comply with approved therapeutic guidelines to enhance the quality of GLP-1 RAs treatment.

Authors

Institutions

Publication Details

Journal
Current Drug Safety
Published
2025-05-07
DOI
https://doi.org/10.2174/0115748863367086250420011411
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Descriptive Analysis from VigiAccess on Drug-related ProblemsAssociated with the Glucagon-like Peptide-1 Receptor Agonists

Palanisamy Amirthalingam
1 citations
Current Drug Safety
Diabetes Treatment and Management
1.29
article

A Descriptive Analysis from VigiAccess on Drug-related ProblemsAssociated with the Glucagon-like Peptide-1 Receptor Agonists

Palanisamy Amirthalingam
article en
1 citations

Abstract

Qualified healthcare practitioners must educate the patients administering the GLP- 1 RAs to minimize preventable DRPs. Also, careful and frequent monitoring of GLP-1 RAs improves therapeutic outcomes by ruling out DRPs. Healthcare practitioners should comply with approved therapeutic guidelines to enhance the quality of GLP-1 RAs treatment.

Current Drug SafetyVol. 20
University of Tabuk (SA)
Good health and well-being
Openalex Percentile: Top 20%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Descriptive Analysis from VigiAccess on Drug-related ProblemsAssociated with the Glucagon-like Peptide-1 Receptor Agonists — Palanisamy Amirthalingam · Current Drug Safety (2025) | TGRS Research Map | TGRS